Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease

NCT05817799 is registered in ClinicalTrials.gov with Bahria University as lead sponsor.

NCT NCT05817799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05817799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
Lead sponsor
Bahria University
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2023
Completion date
July 10, 2023
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis complication